Opko Health Inc. (OPK) Dividend History

Opko Health Inc. is a healthcare company specializing in the development of innovative diagnostics and pharmaceuticals. Founded in 2007, the company focuses on personalized medicine, providing diagnostic tests and treatments in areas such as oncology, neurology, and infectious diseases. Its portfolio includes bio-pharmaceutical products, laboratory services, and consumer health products aimed at improving patient outcomes through targeted healthcare solutions.

4400 Biscayne Blvd., Miami, FL, 33137
Phone: 305-575-4181
Website: https://www.opko.com

Dividend History

Opko Health Inc. currently does not pay dividends

Company News

  • Entera Bio Beats Q2 EPS Estimates

    Entera Bio reported better-than-expected Q2 2025 earnings with a GAAP EPS of $0.06, secured FDA regulatory concurrence for EB613's Phase 3 trial, and maintained a strong cash position of $18.8 million to support operations through mid-Q3 2026.

    The Motley Fool
    Featured Companies: ENTX
  • NextPlat Issues Interim CEO Update Shareholder Letter

    NextPlat's interim CEO David Phipps outlined strategic plans to improve healthcare and e-commerce divisions, focusing on operational efficiency, cost reduction, and exploring growth opportunities following the unexpected passing of former CEO Charles M. Fernandez.

    Benzinga
    Featured Companies: NXPL
  • OPKO Health to Participate in the 3rd Annual Piper Sandler Virtual Obesity Symposium

    OPKO Health, Inc. and Entera Bio Ltd. announced that OPKO's ModeX Therapeutics division has formed a Scientific Advisory Board with leaders in immunology and oncology drug development. Additionally, OPKO and Entera's first-in-class dual GLP-1/Glucagon tablet candidate for obesity and metabolic disorders has been selected for presentation at the ENDO 2025 Annual Meeting.

    GlobeNewswire Inc.
    Featured Companies: ENTX
  • Opko Health sells $823k of GeneDx holdings shares - Investing.com

    Opko Health, a significant shareholder in GeneDx Holdings Corp., has sold a portion of its stake in the company, selling 25,000 shares for a total transaction value of approximately $823,187.

    Investing.com
    Featured Companies: WGS
  • Why Is OPKO Health (OPK) Up 12.8% Since Last Earnings Report?

    OPKO Health (OPK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

    Zacks Investment Research
    Featured Companies: TNDM
Page data last updated 09/07/2025 04:12:47 UTC